6-K

REPORT OF FOREIGN PRIVATE ISSUER

Company: Akari Therapeutics Plc
Filed: April 30, 2013
Period of Report: April 30, 2013
Accession Number: 0001144204-13-024926

View Document ↗ View on SEC.gov ↗